Hospitals & Healthcare Services: Q1 FY27 results (April-June 2026)

31 companies have declared Hospitals & Healthcare Services Q1 FY27 results so far, the latest on 28 Sep 2026.

Across the 24 non-financial companies with a year-ago quarter to compare, sales grew +28.2% and net profit +4.9% year on year, and the combined operating margin narrowed 94 bps to 22.6%.

75% of companies grew net profit; 1 turned a loss into a profit; 29% beat their own profit trend and 38% fell short of it.

Updated 12 Oct 2026, 14:33 IST 31 declared 112 due in the next 3 days →

Hospitals & Healthcare Services Q1 FY27 scoreboard

Sales growth
+28.2%
YoY, 24 companies combined; median +20.0%
Net profit growth
+4.9%
YoY combined; median +25.7%
Operating margin
22.6%
-94 bps YoY
Grew profit
75%
1 turnaround, 0 into loss
Vs own profit trend
29% / 38%
above / below, 33% in line
Price since results
-8.1%
median; 12% of 25 stocks up
Other-income heavy
7
25%+ of pre-tax profit from other income & one-offs

7 matching results 7

Krsnaa Diagnostics Limited

KRSNAA · Hospitals & Healthcare Services · Q1 FY27 · Consolidated · Filed
M Cap
₹1,737 Cr
P/E
17.8
PEG
0.99
Since results
-3.5%
  • Profit -32% below its own trend
  • Operating margin contracted 202 bps YoY
  • 32% of pre-tax profit came from other income and one-off items
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +22.1%+22.0% 236193193
Operating profit +12.8%+5.4% 58.055.051.4
OPM % -202 bps-388 bps 24.6%28.5%26.6%
Other income +83.3%-77.4% 7.232.04.0
Net profit -19.3%-60.6% 16.642.020.5
PAT margin % -361 bps-1473 bps 7.0%21.8%10.6%
EPS (₹) -19.7%-60.3% 5.1012.866.35

Quality of profit

Core 68%Other income & one-offs 32%

Pre-tax profit ₹22.4 Cr: core business ₹15.2 Cr, other income ₹7.2 Cr.

Core profit YoY: -35.3% · reported profit -19.3%

Cash & debt

FY26 cash from operations ₹143 Cr: 141% of FY26 net profit of ₹102 Cr.

Borrowings ₹534 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹207₹236 +13.9% above
Net profit₹24.3₹16.6 -31.8% below
AI read of the filing KRSNAA Q1 Revenue Up 22% to ₹235.5 Cr; Promoters to Infuse Capital via 16.21 Lakh Warrants Watch
  • Revenue from operations grew 22.1% YoY to ₹235.53 Cr from ₹192.98 Cr in the previous year's quarter.
  • Net profit for the quarter fell to ₹16.55 Cr vs ₹20.52 Cr YoY, impacted by finance costs rising to ₹14.83 Cr.
  • Preferential issue of 16.21 lakh warrants to promoters approved at a floor price of ₹565 per warrant.
Full analysis →

Gaudium IVF and Women Health Limited

GAUDIUMIVF · Hospitals & Healthcare Services · Q1 FY27 · Consolidated · Filed
M Cap
₹770 Cr
P/E
—
PEG
—
Since results
-16.7%
  • 46% of pre-tax profit came from other income and one-off items
₹ Cr Jun 2026
Sales 19.4
Operating profit 2.4
OPM % 12.5%
Other income 1.1
Net profit 1.8
PAT margin % 9.2%
EPS (₹) 0.25

Mar 2026 and Jun 2025 are not on record for this company, so there is nothing to compare with yet.

Quality of profit

Core 54%Other income & one-offs 46%

Pre-tax profit ₹2.4 Cr: core business ₹1.3 Cr, other income ₹1.1 Cr.

AI read of the filing Gaudium IVF Q1 PAT at ₹1.66 Cr; IPO Debt Repayment of ₹18.07 Cr Completed Neutral
  • Revenue from operations stood at ₹13.67 cr for the quarter ended June 30, 2026.
  • Net profit decreased to ₹1.66 cr from ₹7.73 cr in the preceding quarter (March 2026).
  • Completed repayment of ₹18.07 cr in borrowings using IPO proceeds, achieving zero-debt status.
Full analysis →

Shalby Limited

SHALBY · Hospitals & Healthcare Services · Q1 FY27 · Consolidated · Filed
M Cap
₹1,418 Cr
P/E
38.3
PEG
—
Since results
-16.1%
  • Profit -24% below its own trend
  • Operating margin contracted 146 bps YoY
  • 38% of pre-tax profit came from other income and one-off items
  • Profit grew faster than the core business (core profit -22%)
  • FY26 operating cash flow was only 0% of profit
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +11.7%+15.4% 331287296
Operating profit +0.1%+43.4% 41.629.041.5
OPM % -146 bps+245 bps 12.6%10.1%14.0%
Other income +5.8%-7.3% 7.48.07.0
Net profit +36.7%-41.7% 10.518.07.7
PAT margin % +58 bps-310 bps 3.2%6.3%2.6%
EPS (₹) +38.0%-42.4% 0.981.700.71

Quality of profit

Core 62%Other income & one-offs 38%

Pre-tax profit ₹19.7 Cr: core business ₹12.3 Cr, other income ₹7.4 Cr.

Core profit YoY: -21.5% · reported profit +36.7%

Cash & debt

FY26 cash from operations ₹0.0 Cr: 0% of FY26 net profit of ₹34.2 Cr.

Borrowings ₹595 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹316₹331 +4.9% in line
Net profit₹13.8₹10.5 -24.2% below
AI read of the filing Shalby Q1 Revenue Grows 11.7% YoY to ₹331 Cr; Appoints Shanay Shah as Whole-Time Director Neutral
  • Consolidated revenue for Q1 FY27 reached ₹331.22 Cr, up 11.7% YoY from ₹296.43 Cr.
  • Healthcare Services segment revenue grew to ₹288.81 Cr, contributing 87% of total revenue.
  • Manufacturing & Trading of Implants segment reported a loss of ₹11.48 Cr, widening from a ₹9.91 Cr loss in Q1 FY26.
Full analysis →

Poly Medicure Limited

POLYMED · Hospitals & Healthcare Services · Q1 FY27 · Consolidated · Filed
M Cap
₹16,087 Cr
P/E
51.4
PEG
2.14
Since results
-5.7%
  • Operating margin contracted 251 bps YoY
  • 30% of pre-tax profit came from other income and one-off items
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +30.3%-1.8% 525535403
Operating profit +17.9%+13.7% 125110106
OPM % -251 bps+325 bps 23.8%20.6%26.3%
Other income -19.9%+75.8% 33.419.041.7
Net profit -8.4%+31.2% 85.365.093.1
PAT margin % -685 bps+408 bps 16.2%12.1%23.1%
EPS (₹) -7.6%+29.8% 8.496.549.19

Quality of profit

Core 70%Other income & one-offs 30%

Pre-tax profit ₹117 Cr: core business ₹82.3 Cr, other income ₹33.4 Cr, exceptional & other items ₹1.6 Cr.

Core profit YoY: +3.0% · reported profit -8.4%

Cash & debt

FY26 cash from operations ₹246 Cr: 77% of FY26 net profit of ₹321 Cr.

Borrowings ₹354 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹458₹525 +14.8% above
Net profit₹87.9₹85.3 -3.0% in line
AI read of the filing Q1 FY27 Results: Revenue Grows 30% YoY to ₹525 Cr; PAT Declines 8% to ₹85 Cr Neutral
  • Consolidated Revenue from operations increased 30.3% YoY to ₹525.38 Cr from ₹403.21 Cr.
  • Consolidated Net Profit (PAT) decreased 8.4% YoY to ₹85.27 Cr compared to ₹93.08 Cr in the year-ago quarter.
  • Employee benefit expenses surged 70.6% YoY to ₹126.90 Cr, impacting operating margins.
Full analysis →

Healthcare Global Enterprises Limited

HCG · Hospitals & Healthcare Services · Q1 FY27 · Consolidated · Filed
M Cap
₹8,797 Cr
P/E
264.5
PEG
—
Since results
-12.4%
  • Profit +361% above its own trend
  • 59% of pre-tax profit came from other income and one-off items
  • Profit grew faster than the core business (core profit +133%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +13.1%+6.3% 693652613
Operating profit +11.8%-3.6% 121125108
OPM % -19 bps-179 bps 17.4%19.2%17.6%
Other income +96.7%from loss 14.8-18.37.5
Net profit +175.3%+307.4% 16.54.06.0
PAT margin % +140 bps+175 bps 2.4%0.6%1.0%
EPS (₹) +187.5%+513.3% 0.920.150.32

Quality of profit

Core 41%Other income & one-offs 59%

Pre-tax profit ₹25.0 Cr: core business ₹10.3 Cr, other income ₹14.8 Cr.

Core profit YoY: +132.7% · reported profit +175.3%

Cash & debt

FY26 cash from operations ₹347 Cr: 1523% of FY26 net profit of ₹22.8 Cr.

Borrowings ₹1,735 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹706₹693 -1.8% in line
Net profit₹3.6₹16.5 +361.2% above
AI read of the filing HCG Q1 FY27 Net Profit Surges 190% to ₹13.77 Cr; Completes ₹37.64 Cr Milann Divestment Positive
  • Consolidated Total Income grew 14.1% YoY to ₹707.23 Cr from ₹619.99 Cr.
  • Net Profit attributable to equity holders surged 190% YoY to ₹13.77 Cr.
  • Completed divestment of BACC Healthcare (Milann) for ₹37.64 Cr on June 29, 2026.
Full analysis →

Krishna Institute of Medical Sciences Limited

KIMS · Hospitals & Healthcare Services · Q1 FY27 · Consolidated · Filed
M Cap
₹28,230 Cr
P/E
145.2
PEG
—
Since results
-14.7%
  • Profit -24% below its own trend
  • Operating margin contracted 319 bps YoY
  • 31% of pre-tax profit came from other income and one-off items
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +35.3%+9.7% 1,1801,075872
Operating profit +15.8%+8.4% 223206193
OPM % -319 bps-22 bps 18.9%19.2%22.1%
Other income +148.6%— 17.41.07.0
Net profit -56.0%+13.3% 37.433.085.0
PAT margin % -658 bps+10 bps 3.2%3.1%9.7%
EPS (₹) -46.9%-1.9% 1.041.061.96

Quality of profit

Core 69%Other income & one-offs 31%

Pre-tax profit ₹56.6 Cr: core business ₹39.2 Cr, other income ₹17.4 Cr.

Core profit YoY: -63.4% · reported profit -56.0%

Cash & debt

FY26 cash from operations ₹511 Cr: 211% of FY26 net profit of ₹242 Cr.

Borrowings ₹4,253 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹1,116₹1,180 +5.7% above
Net profit₹49.4₹37.4 -24.3% below
AI read of the filing KIMS Q1 Results: Rs 1,500 Cr QIP Completed; Consolidated PAT Drops 47% YoY to Rs 41.5 Cr Watch
  • Completed Rs 1,500 Cr QIP by issuing 1.98 Cr shares at Rs 755 each
  • Consolidated PAT attributable to owners declined to Rs 41.5 Cr from Rs 78.6 Cr in the year-ago quarter
  • Board approved a Rs 650 Cr limit for loans, guarantees, or securities to group entities
Full analysis →

Fabtech Technologies Limited

FABTECH · Hospitals & Healthcare Services · Q1 FY27 · Consolidated · Filed
M Cap
₹592 Cr
P/E
40.9
PEG
—
Since results
-12.4%
  • Turnaround: profit against a loss a year ago
  • Operating margin expanded 1479 bps YoY
  • 60% of pre-tax profit came from other income and one-off items
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +10.3%-52.7% 75.015968.0
Operating profit from loss-80.9% 4.222.2-6.2
OPM % +1479 bps-835 bps 5.7%14.0%-9.1%
Other income +15.1%-67.9% 3.29.82.8
Net profit from loss-80.9% 4.222.1-6.1
PAT margin % +1463 bps-830 bps 5.6%13.9%-9.0%
EPS (₹) from loss-80.8% 0.954.96-1.89

Quality of profit

Core 40%Other income & one-offs 60%

Pre-tax profit ₹5.2 Cr: core business ₹2.1 Cr, other income ₹3.2 Cr.

Core profit YoY: from loss

AI read of the filing Fabtech Q1 Revenue Grows 10.2% to ₹74.98 Cr; Announces ₹0.60 Dividend Positive
  • Consolidated revenue from operations increased to ₹74.98 crore in Q1 FY27 from ₹68.01 crore in Q1 FY26.
  • Final dividend of ₹0.60 per equity share (face value ₹10) recommended for shareholder approval.
  • UAE subsidiary (Fabtech Technologies LLC) reported standalone revenue of ₹28.51 crore and net profit of ₹3.81 crore.
Full analysis →

How to read this page

The numbers. Each card is one company's Q1 FY27 results as filed with NSE or BSE, read from the filing within hours of its release, in ₹ crore. We show the consolidated statement, or the standalone one when the consolidated figures are a copy of it or have no year-ago quarter to compare with. YoY compares with the same quarter a year earlier and QoQ with the quarter before (the previous half-year for companies that report every six months). A swing between profit and loss is described in words: a percentage across it would mislead.

Margins. Operating margin (OPM) is operating profit, before depreciation, interest and other income, as a share of sales; PAT margin is net profit as a share of sales. Their changes are in basis points (100 bps = 1 percentage point).

Quality of profit. Core profit is operating profit minus interest and depreciation: what the business itself earned before tax. The rest of pre-tax profit is other income (interest on cash, dividends, gains on investments) and exceptional or one-off items. We flag a quarter when that share is 25% or more, and when reported profit grew much faster than core profit. For banks we compare pre-provision profit with net profit, since a fall in provisions can lift profit without the business growing.

Against its own trend. We do not have analyst consensus estimates, and we do not make them up. Instead each company is measured against the path it was on: the same quarter last year, grown at the median of its last four year-on-year growth rates (held between −50% and +100%; at least two growth rates needed). Sales 5% or more above that, or net profit 10% or more above, is "above trend"; as far below is "below trend". It answers "was this quarter better or worse than the company's own recent run?", which consensus does not.

Cash and debt. Profit is an accounting figure; cash is harder to dress up. For each company we show its operating cash flow for the last financial year as a share of that year's net profit (flagged under 50%, or when it is negative despite a profit), and its borrowings at the latest balance sheet against the one six months earlier (flagged at a 25% move). Balance sheets come with the September and March results, cash-flow statements with the March results.

Price since results. The latest close against the last close before the filing (a filing after 3:30 pm counts from the next session). It is a fact about the market's reaction, not advice.

Market cap groups. Large cap is the 100 largest companies by market value and mid cap the next 150 (SEBI's ranking); below that, small cap is ₹5,000 Cr or more, micro cap ₹500 Cr or more, nano cap below.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI